The aberrant expression of EPO and EpoR described in this rat model of CC and confirmed in human cell lines suggests a possible local autocrine and paracrine release of the hormone not only for direct tumor survival and proliferation, but also for the hepatocytes’ response to chronic liver damage, possibly in a synergistic regulatory mechanism with other growth factors. The gene discussed is EPO; the disease is cholangiocarcinoma.